Benjamin Burnett Score: 32
Analyst at
Wells Fargo,
Stifel Nicolaus
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+66.9%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
60%
9 W / 6 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
67%
8 W / 4 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 12 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 12 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
45%
5 W / 6 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
60%
9 W / 6 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 14, 2026 |
Amphastar Pharmaceuticals Inc
AMPH
|
BUY |
$19.00
Est. +4%
|
$18.32 | $20.76 |
Target Met
|
$19.71
+7.6%
|
| May 10, 2026 |
Xenon Pharmaceuticals Inc
XENE
|
BUY |
$69.00
Est. +22%
|
$56.44 | $57.16 |
Pending
|
$52.40
-7.2%
|
| Feb 02, 2026 |
Rapport Therapeutics Inc.
RAPP
|
BUY |
$43.00
Est. +62%
|
$26.61 | $40.82 |
Pending
|
$38.40
+44.3%
|
| Nov 04, 2025 |
Xenon Pharmaceuticals Inc
XENE
|
BUY |
$44.00
Est. +7%
|
$41.12 | $63.95 |
Target Met
|
$52.40
+27.4%
|
| Sep 02, 2025 |
Avadel Pharmaceuticals plc
AVDL
|
BUY |
$16.00
Est. +7%
|
$14.98 | $23.57 |
Target Met
|
$21.64
+44.5%
|
| Apr 01, 2025 |
Revolution Medicines Inc
RVMD
|
BUY |
$64.00
Est. +90%
|
$33.62 | $124.49 |
Target Met
|
$160.06
+376.1%
|
| Nov 13, 2024 |
Atara Biotherapeutics Inc
ATRA
|
BUY |
$10.00
Est. +32%
|
$7.58 | $18.71 |
Target Met
|
$9.96
+31.4%
|
| Sep 11, 2024 |
Beam Therapeutics Inc
BEAM
|
BUY |
$69.00
Est. +196%
|
$23.34 | $35.25 |
Miss
|
$31.12
+33.3%
|
| Aug 14, 2024 |
Fate Therapeutics Inc
FATE
|
BUY |
$5.00
Est. +53%
|
$3.27 | $4.20 |
Miss
|
$2.01
-38.5%
|
| Aug 09, 2024 |
Iovance Biotherapeutics Inc
IOVA
|
BUY |
$23.00
Est. +479%
|
$3.97 | $12.50 |
Miss
|
$4.03
+1.5%
|
| Aug 06, 2024 |
CRISPR Therapeutics AG
CRSP
|
BUY |
$59.00
Est. +18%
|
$50.01 | $71.13 |
Target Met
|
$52.61
+5.2%
|
| May 31, 2024 |
Iovance Biotherapeutics Inc
IOVA
|
BUY |
$28.00
Est. +215%
|
$8.88 | $12.50 |
Miss
|
$4.03
-54.6%
|
| May 15, 2024 |
Arcellx Inc
ACLX
|
BUY |
$83.00
Est. +64%
|
$50.62 | $107.37 |
Target Met
|
$115.07
+127.3%
|
| Jan 28, 2022 |
Iovance Biotherapeutics Inc
IOVA
|
BUY |
$25.00
Est. +66%
|
$15.04 | - | - |
$4.03
-73.2%
|
| Aug 09, 2021 |
Bluebird bio Inc
BLUE
|
BUY |
$18.00
Est. +53%
|
$11.76 | $357.00 |
Target Met
|
$4.97
-57.7%
|
Amphastar Pharmaceuticals Inc
AMPH
May 14, 2026
Signal & Target
BUY
$19.00
Start Price
$18.32
Best Price (1Y)
$20.76
Current Price
$19.71
Return
+7.6%
Xenon Pharmaceuticals Inc
XENE
May 10, 2026
Signal & Target
BUY
$69.00
Start Price
$56.44
Best Price (1Y)
$57.16
Current Price
$52.40
Return
-7.2%
Rapport Therapeutics Inc.
RAPP
Feb 02, 2026
Signal & Target
BUY
$43.00
Start Price
$26.61
Best Price (1Y)
$40.82
Current Price
$38.40
Return
+44.3%
Xenon Pharmaceuticals Inc
XENE
Nov 04, 2025
Signal & Target
BUY
$44.00
Start Price
$41.12
Best Price (1Y)
$63.95
Current Price
$52.40
Return
+27.4%
Avadel Pharmaceuticals plc
AVDL
Sep 02, 2025
Signal & Target
BUY
$16.00
Start Price
$14.98
Best Price (1Y)
$23.57
Current Price
$21.64
Return
+44.5%
Revolution Medicines Inc
RVMD
Apr 01, 2025
Signal & Target
BUY
$64.00
Start Price
$33.62
Best Price (1Y)
$124.49
Current Price
$160.06
Return
+376.1%
Atara Biotherapeutics Inc
ATRA
Nov 13, 2024
Signal & Target
BUY
$10.00
Start Price
$7.58
Best Price (1Y)
$18.71
Current Price
$9.96
Return
+31.4%
Beam Therapeutics Inc
BEAM
Sep 11, 2024
Signal & Target
BUY
$69.00
Start Price
$23.34
Best Price (1Y)
$35.25
Current Price
$31.12
Return
+33.3%
Fate Therapeutics Inc
FATE
Aug 14, 2024
Signal & Target
BUY
$5.00
Start Price
$3.27
Best Price (1Y)
$4.20
Current Price
$2.01
Return
-38.5%
Iovance Biotherapeutics Inc
IOVA
Aug 09, 2024
Signal & Target
BUY
$23.00
Start Price
$3.97
Best Price (1Y)
$12.50
Current Price
$4.03
Return
+1.5%
CRISPR Therapeutics AG
CRSP
Aug 06, 2024
Signal & Target
BUY
$59.00
Start Price
$50.01
Best Price (1Y)
$71.13
Current Price
$52.61
Return
+5.2%
Iovance Biotherapeutics Inc
IOVA
May 31, 2024
Signal & Target
BUY
$28.00
Start Price
$8.88
Best Price (1Y)
$12.50
Current Price
$4.03
Return
-54.6%
Arcellx Inc
ACLX
May 15, 2024
Signal & Target
BUY
$83.00
Start Price
$50.62
Best Price (1Y)
$107.37
Current Price
$115.07
Return
+127.3%
Iovance Biotherapeutics Inc
IOVA
Jan 28, 2022
Signal & Target
BUY
$25.00
Start Price
$15.04
Best Price (1Y)
-
Current Price
$4.03
Return
-73.2%
Bluebird bio Inc
BLUE
Aug 09, 2021
Signal & Target
BUY
$18.00
Start Price
$11.76
Best Price (1Y)
$357.00
Current Price
$4.97
Return
-57.7%